CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 77 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $291 | -69.8% | 7,600 | -81.8% | 0.00% | 0.0% |
| Q1 2023 | $963 | +164.6% | 41,700 | +200.0% | 0.00% | -50.0% |
| Q4 2022 | $364 | -99.9% | 13,900 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $273,000 | +284.5% | 13,900 | +239.0% | 0.00% | – |
| Q2 2022 | $71,000 | -31.1% | 4,100 | -43.8% | 0.00% | – |
| Q2 2021 | $103,000 | +110.2% | 7,300 | +128.1% | 0.00% | – |
| Q1 2021 | $49,000 | -2.0% | 3,200 | 0.0% | 0.00% | – |
| Q4 2020 | $50,000 | – | 3,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $198,319,737 | 34.81% |
| Saturn V Capital Management LP | 524,811 | $20,163,239 | 11.18% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $166,956,377 | 9.97% |
| Altium Capital Management LP | 305,000 | $11,718,100 | 8.87% |
| MPM BioImpact LLC | 1,003,406 | $38,550,859 | 7.76% |
| Affinity Asset Advisors, LLC | 321,017 | $12,333,473 | 4.31% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,131,000 | $81,873,020 | 3.69% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,748,141 | $67,163,577 | 3.59% |
| Nan Fung Group Holdings Ltd | 113,950 | $4,377,959 | 2.80% |
| Vivo Capital, LLC | 934,879 | $35,918,051 | 2.48% |